Laurs & Bridz Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.40 M
as on 17-12-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
as on 17-12-2024
- Revenue -32.51%
(FY 2020)
- Profit -26.18%
(FY 2020)
- Ebitda 23.94%
(FY 2020)
- Net Worth 3.57%
(FY 2020)
- Total Assets 8.95%
(FY 2020)
About Laurs & Bridz Pharmaceuticals
The Corporate was formerly known as Laurs & Bridz Salesmart Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹0.50 M.
Manu Chaudhary and Shubha Goel serve as directors at the Company.
- CIN/LLPIN
U24233UP2011PTC044425
- Company No.
044425
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Laurs & Bridz Pharmaceuticals Private Limited offer?
Laurs & Bridz Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Multivitamin Syrup & Drops, Vitamin B Complex Syrup, Antibiotic Tablets & Capsules, Azithromycin Tablets, Antihistamines, Levocetirizine Tablet, Cefixime Ofloxacin Tablets, Cefixime Tablet.
Who are the key members and board of directors at Laurs & Bridz Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manu Chaudhary  | Director | 11-Nov-2021 | Current |
| Shubha Goel | Additional Director | 02-Dec-2019 | Current |
Financial Performance of Laurs & Bridz Pharmaceuticals.
Laurs & Bridz Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 32.51% decrease. The company also saw a substantial fall in profitability, with a 26.18% decrease in profit. The company's net worth moved up by a moderate rise of 3.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laurs & Bridz Pharmaceuticals?
In 2020, Laurs & Bridz Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 26 Apr 2017 | ₹0.50 M | Open |
How Many Employees Work at Laurs & Bridz Pharmaceuticals?
Unlock and access historical data on people associated with Laurs & Bridz Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laurs & Bridz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laurs & Bridz Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
